Mia's Feed
Medical News & Research

Link Between Blood Vessel Dysfunction and Muscle Wasting in Cancer Patients

Link Between Blood Vessel Dysfunction and Muscle Wasting in Cancer Patients

Share this article

New research uncovers how blood vessel dysfunction contributes to muscle wasting in cancer, pointing to potential new treatments to improve patient strength and outcomes.

2 min read

A recent study from the University of Illinois Chicago has highlighted a significant connection between impaired blood vessel function and muscle wasting, known as cachexia, in cancer patients. The research suggests that poor blood vessel health within muscles contributes to weakness and weight loss commonly seen in metastasis and advanced stages of cancer.

Blood vessels are essential not only for delivering nutrients and oxygen to muscles but also for maintaining overall organ health. The study utilized high-resolution 3D microscopy in animal models of various cancers, including pancreatic, colon, lung, and melanoma. Findings revealed that muscles affected by cachexia had fewer and less healthy blood vessels, alongside reduced muscle mass and thinner fibers, resulting in diminished strength.

Further analysis showed that endothelial cells lining the blood vessels in cachectic muscles exhibited signs of aging, increased leakiness, and higher rates of cell death. A key molecule called activin A was found to be elevated in these endothelial cells, which suppressed the expression of PGC1α, a protein vital for blood vessel health and muscle integrity. Restoring PGC1α levels improved blood vessel function and muscle strength, indicating a potential therapeutic target.

The research highlights that vascular dysfunction plays a critical role in the progression of cachexia, and addressing this could help improve muscle function and patient outcomes. Currently, there are no FDA-approved treatments specifically targeting cachexia, and conventional approaches like nutrition and exercise often fall short. Future therapies aimed at modulating activin A and PGC1α levels in blood vessels are promising avenues for combating muscle wasting in cancer patients.

Understanding the role of blood vessels in muscle health opens new pathways for treatment, with the potential to enhance quality of life and survival rates among cancer sufferers. The study emphasizes that maintaining healthy vasculature is crucial in preventing and potentially reversing muscle wasting associated with cancer.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Social Media's Mixed Messages About Food and Body Image Uncovered in New Study

New research reveals that social media food videos often promote conflicting messages about eating habits and body image, potentially impacting viewers' health and perceptions. Learn about the findings and implications for online content regulation.

Simple, Non-Drug Therapies Show Greater Effectiveness for Knee Osteoarthritis Management

A new meta-analysis reveals that simple therapies like knee braces, water therapy, and exercise outperform high-tech options for knee osteoarthritis pain relief and mobility improvement.

Maintenance Combination of Lurbinectedin and Atezolizumab Improves Survival in Lung Small Cell Carcinoma

A combination of lurbinectedin and atezolizumab as maintenance therapy significantly improves survival in extensive-stage small cell lung cancer, according to new research presented at ASCO 2025.

Innovative Engineered CAR-NK Cells Show Promise in Evasion of Immune Rejection and Enhanced Cancer Targeting

Researchers have developed engineered CAR-NK cells that can evade immune rejection and target cancer cells more effectively, promising safer and more accessible immunotherapy options.